Published in J Ethnopharmacol on July 01, 2000
An inducible NADPH-cytochrome P450 reductase from Picrorhiza kurrooa - an imperative redox partner of cytochrome P450 enzymes. Funct Integr Genomics (2014) 0.81
Mass spectrometric analysis of differentially expressed proteins in an endangered medicinal herb, Picrorhiza kurroa. Biomed Res Int (2014) 0.75
Phytochemical studies for quantitative estimation of iridoid glycosides in Picrorhiza kurroa Royle. Bot Stud (2016) 0.75
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. J Clin Oncol (2011) 6.16
Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J Natl Cancer Inst (2010) 3.08
A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer. Mol Cancer Ther (2011) 2.74
Tumor-initiating cells are rare in many human tumors. Cell Stem Cell (2010) 2.54
Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett (1995) 2.52
Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer. Mol Cancer Ther (2010) 2.21
Anti-diabetic activity of Picrorrhiza kurroa extract. J Ethnopharmacol (1999) 1.89
Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett (1985) 1.79
Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer. Cancer Res (2008) 1.69
Tumor engraftment in nude mice and enrichment in stroma- related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer. Clin Cancer Res (2011) 1.59
Immunomodulatory and antitumor activity of Piper longum Linn. and piperine. J Ethnopharmacol (2004) 1.48
Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol (1992) 1.44
Cytotoxic and anti-tumour properties of certain taxa of Umbelliferae with special reference to Centella asiatica (L.) Urban. J Ethnopharmacol (1995) 1.31
sym-Homospermidine, a naturally occurring polyamine. Biochemistry (1971) 1.29
Characterizing DNA methylation patterns in pancreatic cancer genome. Mol Oncol (2009) 1.29
Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Lett (1995) 1.28
Effect of Emblica officinalis, Phyllanthus amarus and Picrorrhiza kurroa on N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Lett (1999) 1.27
Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. Cancer Lett (2013) 1.22
Immunomodulatory activity of Withania somnifera. J Ethnopharmacol (2000) 1.22
Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer. Br J Cancer (2010) 1.21
Turmeric and curcumin as topical agents in cancer therapy. Tumori (1987) 1.19
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models. Cancer Biol Ther (2011) 1.18
Biochemistry of the hydroxyprolines. Adv Enzymol Relat Areas Mol Biol (1973) 1.17
The biosynthesis of cis-4-hydroxy-L-proline in sandal (Santalum album L.). Biochem J (1970) 1.10
Anti-metastatic activity of curcumin and catechin. Cancer Lett (1999) 1.08
Inhibition of chemical carcinogenesis by berberine in rats and mice. J Pharm Pharmacol (2001) 1.06
Effect of Withania somnifera on DMBA induced carcinogenesis. J Ethnopharmacol (2001) 1.06
Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer. Invest New Drugs (2012) 1.05
Piperine is a potent inhibitor of nuclear factor-kappaB (NF-kappaB), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells. Int Immunopharmacol (2004) 1.04
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies. Integr Cancer Ther (2005) 1.03
A fine-needle aspirate-based vulnerability assay identifies polo-like kinase 1 as a mediator of gemcitabine resistance in pancreatic cancer. Mol Cancer Ther (2010) 1.03
Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett (1995) 1.02
Antioxidant activity of Tinospora cordifolia and its usefulness in the amelioration of cyclophosphamide induced toxicity. J Exp Clin Cancer Res (1997) 1.02
Conceptual framework for cutting the pancreatic cancer fuel supply. Clin Cancer Res (2012) 1.02
Antioxidant and anti-inflammatory activities of the plant Andrographis paniculata Nees. Immunopharmacol Immunotoxicol (2006) 1.01
Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts. Mol Cancer Ther (2009) 1.01
Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin. Indian J Physiol Pharmacol (1992) 1.00
Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth. Mol Cancer Ther (2011) 1.00
Hepatoprotective activity of Emblica officinalis and Chyavanaprash. J Ethnopharmacol (2000) 1.00
The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models. Mol Cancer Ther (2012) 0.99
Inhibition of liver fibrosis by ellagic acid. Indian J Physiol Pharmacol (1996) 0.98
Antitumour activity of Emblica officinalis. J Ethnopharmacol (2001) 0.98
Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system. Phytomedicine (2003) 0.98
Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice. Clin Exp Metastasis (2002) 0.98
Inhibition of chemical carcinogenesis by curcumin. J Ethnopharmacol (1989) 0.97
Clinical trial of certain ayurvedic medicines indicated in vitiligo. Anc Sci Life (1990) 0.97
Suppressive effect of cyclophosphamide-induced toxicity by Withania somnifera extract in mice. J Ethnopharmacol (1998) 0.95
Tumour reducing and anticarcinogenic activity of selected spices. Cancer Lett (1990) 0.95
Activation of cytotoxic T lymphocyte responses and attenuation of tumor growth in vivo by Andrographis paniculata extract and andrographolide. Immunopharmacol Immunotoxicol (2007) 0.94
Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity. Cancer Lett (1997) 0.94
Reversal of aflatoxin induced liver damage by turmeric and curcumin. Cancer Lett (1992) 0.94
Preparation and composition of alveolar extracellular matrix and incorporated basement membrane. Lung (1981) 0.93
Phyllanthus amarus extract administration increases the life span of rats with hepatocellular carcinoma. J Ethnopharmacol (2000) 0.93
Inhibition of tumor specific angiogenesis by amentoflavone. Biochemistry (Mosc) (2008) 0.91
Activation of prolyl hydroxylase in fibroblasts by ascorbic acid. Ann N Y Acad Sci (1975) 0.91
Inhibition of tumour promotion in mice by eugenol. Indian J Physiol Pharmacol (1994) 0.91
Inhibition of inosinate dehydrogenase by metabolites of 2-beta-D-ribofuranosyl thiazole-4-carboxamide. Biochem Biophys Res Commun (1982) 0.90
Homeopathic medicines do not alter growth and gene expression in prostate and breast cancer cells in vitro. Integr Cancer Ther (2006) 0.90
Effect of a preparation from Viscum album on tumor development in vitro and in mice. J Ethnopharmacol (1990) 0.90
Chemoprotective activity of an extract of Phyllanthus amarus against cyclophosphamide induced toxicity in mice. Phytomedicine (2005) 0.89
Immunomodulatory activity of naturally occurring monoterpenes carvone, limonene, and perillic acid. Immunopharmacol Immunotoxicol (2003) 0.89
Screening of 11 ferns for cytotoxic and antitumor potential with special reference to Pityrogramma calomelanos. J Ethnopharmacol (1991) 0.89
Antiangiogenic activity of Andrographis paniculata extract and andrographolide. Int Immunopharmacol (2006) 0.88
Effect of Withania somnifera on CTL activity. J Exp Clin Cancer Res (2002) 0.88
An activatable form of prolyl hydroxylase in fibrobalast extracts. Biochem Biophys Res Commun (1975) 0.88
Protective effect of curcumin, ellagic acid and bixin on radiation induced toxicity. Indian J Exp Biol (1996) 0.88
Effect of Tinospora cordifolia on the cytokine profile of angiogenesis-induced animals. Int Immunopharmacol (2004) 0.87
Inhibitory effect of a polysaccharide from Tinospora cordifolia on experimental metastasis. J Ethnopharmacol (2004) 0.87
Immunomodulatory activity of curcumin. Immunol Invest (1999) 0.87
Antioxidant activity of brahma rasayana. Indian J Exp Biol (2001) 0.87
Immunomodulatory activity of Sulforaphane, a naturally occurring isothiocyanate from broccoli (Brassica oleracea). Phytomedicine (2006) 0.87
Studies on the biosynthesis of sym-homospermidine in sandal (Santalum album L.). Biochem J (1972) 0.87
Protective effect of a polyherbal preparation, Brahma rasayana against tumor growth and lung metastasis in rat prostate model system. J Exp Ther Oncol (2004) 0.87
Effect of isoflavones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells. Nutr Cancer (1998) 0.87
Protective effect of curcumin, ellagic acid and bixin on radiation induced genotoxicity. J Exp Clin Cancer Res (1998) 0.86
Myeloprotective effect of a non-toxic indigenous preparation Rasayana in cancer patients receiving chemotherapy and radiation therapy. A pilot study. J Exp Clin Cancer Res (1999) 0.86
Immunomodulatory activity of a peptide isolated from Viscum album extract (NSC 635 089). Immunol Invest (1992) 0.86
Induction of apoptosis in mouse and human carcinoma cell lines by Emblica officinalis polyphenols and its effect on chemical carcinogenesis. J Exp Clin Cancer Res (2003) 0.86
Effect of naturally occurring isothiocyanates in the inhibition of cyclophosphamide-induced urotoxicity. Phytomedicine (2005) 0.86
Effect of Withania somnifera on 20-methylcholanthrene induced fibrosarcoma. J Exp Clin Cancer Res (2000) 0.85
Regulation of Caspase-3 and Bcl-2 Expression in Dalton's Lymphoma Ascites Cells by Abrin. Evid Based Complement Alternat Med (2007) 0.84
Cytotoxicity of extracts of spices to cultured cells. Nutr Cancer (1988) 0.84
Augmentation of natural killer cell and antibody-dependent cellular cytotoxicity in BALB/c mice by sulforaphane, a naturally occurring isothiocyanate from broccoli through enhanced production of cytokines IL-2 and IFN-gamma. Immunopharmacol Immunotoxicol (2006) 0.84
A preliminary study on antimetastatic activity of Thuja occidentalis L. in mice model. Immunopharmacol Immunotoxicol (2006) 0.84
The isolation and characterization of gamma-L-glutamyl-S-(trans-1-propenyl)-L-cysteine sulfoxide from sandal (Santalum album L). An interesting occurrence of sulfoxide diastereoisomers in nature. Biochemistry (1974) 0.84
Isolation and identification of a tumour reducing component from mistletoe extract (Iscador). Cancer Lett (1988) 0.84
Effect of naturally occurring triterpenoids ursolic acid and glycyrrhizic acid on the cell-mediated immune responses of metastatic tumor-bearing animals. Immunopharmacol Immunotoxicol (2008) 0.84
Modulation of cell-mediated immune response in B16F-10 melanoma-induced metastatic tumor-bearing C57BL/6 mice by sulforaphane. Immunopharmacol Immunotoxicol (2007) 0.84
Effect of "rasayanas", a herbal drug preparation on immune responses and its significance in cancer treatment. Indian J Exp Biol (1999) 0.83